Herein, we explored the expression and prognostic effects of KK-LC-1 on patients with triple-negative breast cancer and the role of KK-LC-1 expression in the development of triple-negative breast cancer using in vitro and in vivo experiments. Here, CT83 is linked to triple-negative breast carcinoma.